Business & Economics :: Plant Watch, Mergers and Business News
January 8, 2013
Lonza to expand ADC manufacturing capacity
Lonza (Basel, Switzerland; www.lonza.com) plans to invest CHF14 million (about $15 million) to expand Antibody Drug Conjugate (ADC) manufacturing capacity in Visp, Switzerland. Oncology therapeutics including ADCs represent one of the fastest growing segments...
This information is only available to Gold members.
Forgot your user ID or password? Click here to have it sent to you.
Not a member yet?
UPGRADE now to full archive accces and you will receive:
A discount on full delegate pass to ChemInnovations.